Chemoattractants and receptors in Alzheimer's disease

Frontiers in Bioscience - Scholar

Volumn 2 S, Issue 2, 2010, Pages 504-514

  Ruan, Lingfei ^a   Kong, Yan ^a   Wang, Ji Ming ^b   Le, Yingying ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Chemoattractants; Chemokines; Receptors; Review

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOTACTIC FACTOR; FORMYLPEPTIDE RECEPTOR;

ALZHEIMER DISEASE; BRAIN; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; BRAIN; CHEMOKINES; CHEMOTACTIC FACTORS; HUMANS; RECEPTORS, CHEMOKINE; RECEPTORS, FORMYL PEPTIDE;

EID: 77957318195     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. PM Murphy: International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 54, 227-229 (2002) (Pubitemid 34575712)
2. A Zlotnik, O Yoshie, H Nomiyama: The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7, 243 (2006)
3. Y Le, Y Cui, P Iribarren, G Ying, JM Wang: Manipulating chemoattractant and receptor genes. in vivo 16, 1-23 (2002) (Pubitemid 34441003)
4. Y Le, W Gong, W Shen, B L.i., NM Dunlop, JM Wang: A burgeoning family of biological mediators: chemokines and chemokine receptors. Arch Immunol Ther Exp (Warsz) 48, 143-150 (2000)
5. R Bonecchi, E Galliera, EM Borroni, MM Corsi, M Locati, A Mantovani: Chemokines and chemokine receptors: an overview. Front Biosci 14, 540-551 (2009)
6. G Banisadr, W Rostène, P Kitabgi, SM Parsadaniantz: Chemokines and brain functions. Curr Drug Targets Inflamm Allergy 4, 387-399 (2005) (Pubitemid 40879603)
7. L Cartier, O Hartley, M Dubois-Dauphin, KH Krause: Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48, 16-42 (2005) (Pubitemid 40215781)
8. K Tahara, HD Kim, JJ Jin, JA Maxwell, L Li, K Fukuchi: Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129, 3006-3019 (2006) (Pubitemid 44684521)
9. Y Verdier, M Zarándi, B Penke: Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J Pept Sci 10, 229-248 (2004) (Pubitemid 38594184)
10. Y Verdier, B Penke: Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease. Curr Protein Pept Sci 5, 19-31 (2004) (Pubitemid 38279402)
11. Y Le, W Gong, HL Tiffany, A Tumanov, S Nedospasov, W Shen, NM Dunlop, JL Gao, PM Murphy, JJ Oppenheim, JM Wang: Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J Neurosci 21, RC123 (2001)
12. HL Tiffany, MC Lavigne, YH Cui, JM Wang, TL Leto, JL Gao, PM Murphy: Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J Biol Chem 276, 23645-23652 (2001)
13. YH Cui, Y L.e., X Zhang, W Gong, K Abe, R Sun, J Van Damme, P Proost, JM Wang: Up-regulation of FPR2, a chemotactic receptor for amyloid beta 1-42 (A beta 42), in murine microglial cells by TNF alpha. Neurobiol Dis 10, 366-377 (2002) (Pubitemid 35217588)
14. H Yazawa, ZX Yu, Takeda, Y Le, W Gong, VJ Ferrans, JJ Oppenheim, CC Li, JM Wang: Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J 15, 2454-2462 (2001) (Pubitemid 33063173)
15. P Iribarren, K Chen, J H.u., W Gong, EH Cho, S Lockett, B Uranchimeg, JM Wang: CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2. FASEB J 19, 2032-2034 (2005) (Pubitemid 41759755)
16. LO Brandenburg, M Konrad, C Wruck, T Koch, T Pufe, R Lucius: Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells. Neuroscience 156, 266-276 (2008)
17. YH Cui, Y L.e., W Gong, P Proost, DJ Van, WJ Murphy, JM Wang: Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J Immunol 168, 434-442 (2002) (Pubitemid 34014146)
18. K Chen, P Iribarren, J H.u., J Chen, W Gong, EH Cho, S Lockett, NM Dunlop, JM Wang: Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J Biol Chem 281, 3651-3659 (2006) (Pubitemid 43845983)
19. B Marcyniuk, DM Mann, PO Yates: Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged. Neurosci Lett 64, 247-252 (1986) (Pubitemid 16163819)
20. W Bondareff, CQ Mountjoy, M Roth, MN Rossor, LL Iversen, GP Reynolds, DL Hauser: Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord 1, 256-262 (1987)
21. A Grudzien, P Shaw, S Weintraub, E Bigio, DC Mash, MM Mesulam: Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 28, 327-35 (2007) (Pubitemid 46178530)
22. D Weinshenker: Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Curr Alzheimer Res 5, 342-345 (2008) (Pubitemid 351840281)
23. MT Heneka, E Galea, V Gavriluyk, L Dumitrescu-Ozimek, J Daeschner, MK O'Banion, G Weinberg, T Klockgether, DL Feinstein: Noradrenergic depletion potentiates beta - amyloid-induced cortical inflammation: implications for Alzheimer's disease. J Neurosci 22, 2434-2442 (2002) (Pubitemid 37465791)
24. S Kalinin, V Gavrilyuk, PE Polak, R Vasser, J Zhao, MT Heneka, DL Feinstein: Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol Aging 28, 1206-1214 (2006)
25. MT Heneka, M Ramanathan, AH Jacobs, L Dumitrescu-Ozimek, A Bilkei-Gorzo, T Debeir, M Sastre, N Galldiks, A Zimmer, M Hoehn, WD Heiss, T Klockgether, M Staufenbiel: Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 26, 1343-1354 (2006) (Pubitemid 43237005)
26. T Arakawa, Y Kita, T Niikura: A rescue factor for Alzheimer's diseases: discovery, activity, structure, and mechanism. Curr Med Chem 15, 2086-2098 (2008)
27. G Ying, P Iribarren, Y Zhou, W Gong, N Zhang, ZX Yu, Y Le, Y Cui, JM Wang: Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol 172, 7078-7085 (2004) (Pubitemid 38669150)
28. M Ikonen, B Liu, Y Hashimoto, L M.a., K W Lee, T Niikura, I Nishimoto, P Cohen: Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A 100, 13042-13047 (2003) (Pubitemid 37340022)
29. K Ishizuka, T Kimura, R Igata-yi, S Katsuragi, J Takamatsu, T Miyakawa: Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 51, 135-138 (1997) (Pubitemid 27262094)
30. A Sokolova, MD Hill, F Rahimi, LA Warden, GM Halliday, CE Shepherd: Monocyte Chemoattractant Protein-1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease. Brain Pathol 19, 392-398 (2008)
31. P Grammas, R Ovase: Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging 22, 837-842 (2001) (Pubitemid 34066550)
32. MC Janelsins, MA Mastrangelo, S Oddo, FM LaFerla, HJ Federoff, WJ Bowers: Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2, 23 (2005)
33. L Ruan, Z Kang, P Pei, Y Le: Amyloid Deposition and Inflammation in APPswe/PS1dE9 Mouse Model of Alzheimer's Disease. Curr Alzheimer Res in press
34. D Galimberti, N Schoonenboom, P Scheltens, C Fenoglio, F Bouwman, E Venturelli, I Guidi, MA Blankenstein, N Bresolin, E Scarpini: Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63, 538-543 (2006)
35. D Galimberti, C Fenoglio, C Lovati, E Venturelli, I Guidi, B Corra, D Scalabrini, F Clerici, C Mariani, N Bresolin, E Scarpini: Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease. Neurobiol Aging 27, 1763-1768 (2006) (Pubitemid 44572579)
36. BH Rovin, L L.u., R Saxena: A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259, 344-348 (1999) (Pubitemid 29281234)
37. R Pola, A Flex, E Gaetani, AS Proia, P Papaleo, GA Di, G Straface, G Pecorini, M Serricchio, P Pola: Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 39, 1249-1252 (2004) (Pubitemid 39024374)
38. O Combarros, J Infante, J Llorca, J Berciano: No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease. Neurosci Lett 360, 25-28 (2004) (Pubitemid 38471979)
39. LF Lue, R Rydel, EF Brigham, LB Yang, H Hampel, GM Murphy, Jr L Brachova, SD Yan, DG Walker, Y Shen, J Rogers: Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35, 72-79 (2001) (Pubitemid 32656755)
40. HA Smits, A Rijsmus, JH van Loon, JW Y Wat, J Verhoef, LA Boven, HS LM Nottet: Amyloid-[beta]-induced chemokine production in primary human macrophages and astrocytes. J Neuroimmunol 127, 160-168 (2002) (Pubitemid 34603587)
41. V Vukic, D Callaghan, D Walker, LF Lue, QY Liu, PO Couraud, IA Romero, B Weksler, DB Stanimirovic, W Zhang: Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis 34, 95-106 (2009)
42. AM Szczepanik, GE Ringheim: IL-10 and glucocorticoids inhibit Abeta (1-42)- and lipopolysaccharide-induced pro-inflammatory cytokine and chemokine induction in the central nervous system. J Alzheimers Dis 5, 105-117 (2003) (Pubitemid 36582770)
43. M Yamamoto, M Horiba, JL Buescher, D Huang, HE Gendelman, RM Ransohoff, T Ikezu: Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition. Am J Pathol 166, 1475-1485 (2005) (Pubitemid 40586517)
44. T Kiyota, M Yamamoto, B Schroder, MT Jacobsen, RJ Swan, MP Lambert, WL Klein, HE Gendelman, RM Ransohoff, T Ikezu: AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice. Mol Ther 17, 803-809 (2009)
45. K Li, D Dai, L Yao, X G.u., K Luan, W Tian, Y Zhao, B Wang: Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimer's disease in the Chinese population. Neurosci Lett 433, 125-128 (2008)
46. I Blasko, W Lederer, H Oberbauer, T Walch, G Kemmler, H Hinterhuber, J Marksteiner, C Humpel: Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord 21, 9-15 (2006) (Pubitemid 41797965)
47. MQ Xia, SX Qin, LJ Wu, CR Mackay, BT Hyman: Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am J Pathol 153, 31-37 (1998) (Pubitemid 28317504)
48. D Tripathy, L Thirumangalakudi, P Grammas: Expression of macrophage inflammatory protein 1-alpha is elevated in Alzheimer's vessels and is regulated by oxidative stress. J Alzheimers Dis 11, 447-455 (2007) (Pubitemid 47094015)
49. SM Man, YR Ma, DS Shang, WD Zhao, B L.i., DW Guo, WG Fang, L Zhu, YH Chen: Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease. Neurobiol Aging 28, 485-496 (2007) (Pubitemid 46282203)
50. L Meda, P Baron, E Prat, E Scarpini, G Scarlato, MA Cassatella, F Rossi: Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J Neuroimmunol 93, 45-52 (1999) (Pubitemid 29051550)
51. RK Giri, V Rajagopal, VK Kalra: Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91, 1199-1210 (2004) (Pubitemid 39587458)
52. D Tripathy, L Thirumangalakudi, P Grammas: RANTES upregulation in the Alzheimer's disease brain: A possible neuroprotective role. Neurobiol Aging [Epub ahead of print] (2008)
53. M Johnstone, AJ Gearing, KM Miller: A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol 93, 182-193 (1999) (Pubitemid 29051564)
54. C Iarlori, D Gambi, F Gambi, I Lucci, C Feliciani, M Salvatore, M Reale: Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease. Exp Gerontol 40, 605-611 (2005) (Pubitemid 41074807)
55. AL Teixeira, HJ Reis, FM Coelho, DS Carneiro, MM Teixeira, LB Vieira, MA Mukhamedyarov, AL Zefirov, Z Janka, A Palotas: All-or-nothing type biphasic cytokine production of human lymphocytes after exposure to Alzheimer's beta-amyloid peptide. Biol Psychiatry 64, 891-895 (2008)
56. V Sharma, M Mishra, S Ghosh, R Tewari, A Basu, P Seth, E Sen: Modulation of interleukin-1[beta] mediated inflammatory response in human astrocytes by flavonoids: Implications in neuroprotection. Brain Res Bull 73, 55-63 (2007) (Pubitemid 46710246)
57. V Bruno, A Copani, G Besong, G Scoto, F Nicoletti: Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur J Pharmacol 399, 117-121 (2000) (Pubitemid 30407031)
58. A Ignatov, J Robert, C Gregory-Evans, HC Schaller: RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75. Br J Pharmacol 149, 490-497 (2006) (Pubitemid 44658509)
59. P Grammas, PG Samany, L Thirumangalakudi: Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implications for disease pathogenesis. J Alzheimers Dis 9, 51-58 (2006)
60. MA Dorheim, WR Tracey, JS Pollock, P Grammas: Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem Biophys Res Commun 205, 659-665 (1994) (Pubitemid 24381677)
61. S Ito, M Sawada, M Haneda, Y Ishida, KI Isobe: Amyloid-[beta] peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K/Akt and/or ERK pathway. Neurosci Res 56, 294-299 (2006) (Pubitemid 44574518)
62. AT Weeraratna, A Kalehua, I Deleon, D Bertak, G Maher, MS Wade, A Lustig, KG Becker, WIII Wood, DG Walker, TG Beach, DD Taub: Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. Exp Cell Res 313, 450-461 (2007) (Pubitemid 46186300)
63. M Halks-Miller, ML Schroeder, V Haroutunian, U Moenning, M Rossi, C Achim, D Purohit, M Mahmoudi, R Horuk: CCR1 is an early and specific marker of Alzheimer's disease. Ann Neurol 54, 638-646 (2003) (Pubitemid 37346070)
64. M Reale, C Iarlori, C Feliciani, D Gambi: Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease. J Alzheimers Dis 14, 147-159 (2008) (Pubitemid 352040032)
65. J El Khoury, M Toft, SE Hickman, TK Means, K Terada, C Geula, AD Luster: Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13, 432-438 (2007) (Pubitemid 46559828)
66. RK Giri, V Rajagopal, S Shahi, BV Zlokovic, VK Kalra: Mechanism of amyloid peptide induced CCR5 expression in monocytes and its inhibition by siRNA for Egr-1. Am J Physiol Cell Physiol 289, C264-C276 (2005) (Pubitemid 41008873)
67. CR Balistreri, MP Grimaldi, S Vasto, F Listi, M Chiappelli, F Licastro, D Lio, C Caruso, G Candore: Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from Northern Italy. Ann N Y Acad Sci 1089, 454-461 (2006) (Pubitemid 47092067)
68. O Combarros, J Infante, J Llorca, N Pena, C Fernandez-Viadero, J Berciano: The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease. Neurosci Lett 366, 312-314 (2004) (Pubitemid 39024288)
69. Y Tamura, Y Sakasegawa, K Omi, H Kishida, T Asada, H Kimura, K Tokunaga, NS Hachiya, K Kaneko, H Hohjoh: Association study of the chemokine, CXC motif, ligand 1 (CXCL1) gene with sporadic Alzheimer's disease in a Japanese population. Neurosci Lett 379, 149-151 (2005) (Pubitemid 40544524)
70. M Xia, BT Hyman: GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-a role in Alzheimer's disease? J Neuroimmunol 122, 55-64 (2002) (Pubitemid 34075490)
71. K Watson, GH Fan: Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol Pharmacol 67, 757-765 (2005) (Pubitemid 40365323)
72. A Parachikova, KE Nichol, CW Cotman: Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition. Neurobiol Dis 30, 121-129 (2008)
73. DG Walker, LF Lue, TG Beach: Gene expression profiling of amyloid beta peptide-stimulated human postmortem brain microglia. Neurobiol Aging 22, 957-966 (2001) (Pubitemid 34066564)
74. SJ Kim, HJ Jeong, BK Kim, NH Kim, JS Kim, KS Choi, HJ Lee, ST Kang, SS Shin, WI Kim, HS Eom, KM Lee, JY Um, SH Hong, HM Kim: Anti-inflammatory effect of jeongshintang through suppression of p38 activation in human astrocytoma, U373MG cells. Exp Mol Pathol 81, 85-91 (2006) (Pubitemid 43949618)
75. M Fiala, L Zhang, X Gan, B Sherry, D Taub, MC Graves, S Hama, D Way, M Weinand, M Witte, D Lorton, Y M Kuo, AE Roher: Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol Med 4, 480-489 (1998) (Pubitemid 28419092)
76. S Franciosi, HB Choi, SU Kim, JG McLarnon: IL-8 enhancement of amyloid-beta (Abeta 1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia. J Neuroimmunol 159, 66-74 (2005) (Pubitemid 40126178)
77. L Thirumangalakudi, L Yin, HV Rao, P Grammas: IL-8 induces expression of matrix metalloproteinases, cell cycle and pro-apoptotic proteins, and cell death in cultured neurons. J Alzheimers Dis 11, 305-311 (2007) (Pubitemid 47094028)
78. M Xia, S Qin, M McNamara, C Mackay, BT Hyman: Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am J Pathol 150, 1267-1274 (1997) (Pubitemid 27152645)
79. P Bakshi, E Margenthaler, V Laporte, F Crawford, M Mullan: Novel role of CXCR2 in regulation of gamma-secretase activity. ACS Chem Biol 3, 777-789 (2008)
80. YJ Liu, DW Guo, L Tian, DS Shang, WD Zhao, B Li, WG Fang, L Zhu, YH Chen: Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-alpha-dependent. Neurobiol Aging [Epub ahead of print] (2008)
81. MQ Xia, BJ Bacskai, RB Knowles, SX Qin, BT Hyman: Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: In vitro ERK1/2 activation and role in Alzheimer's disease. J Neuroimmunol 108, 227-235 (2000) (Pubitemid 30438772)
82. SH Goldberg, MP van der, J Hesselgesser, S Jaffer, DL Kolson, AV Albright, F Gonzalez-Scarano, E Lavi: CXCR3 expression in human central nervous system diseases. Neuropathol Appl Neurobiol 27, 127-138 (2001) (Pubitemid 32591969)
83. RS Duan, X Yang, ZG Chen, MO Lu, C Morris, B Winblad, J Zhu: Decreased fractalkine and increased IP-10 expression in aged brain of APP (swe) transgenic mice. Neurochem Res 33, 1085-1089 (2008)
84. D Galimberti, N Schoonenboom, P Scheltens, C Fenoglio, E Venturelli, YA Pijnenburg, N Bresolin, E Scarpini: Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration. Neurology 66, 146-147 (2006) (Pubitemid 43739618)
85. A Antonelli, M Rotondi, P Fallahi, P Romagnani, SM Ferrari, E Ferrannini, M Serio: Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. J Interferon Cytokine Res 25, 547-552 (2005) (Pubitemid 41395842)
86. H Bruunsgaard, M Pedersen, BK Pedersen: Aging and proinflammatory cytokines. Curr Opin Hematol 8, 131-136 (2001) (Pubitemid 32324632)
87. D Galimberti, E Venturelli, C Fenoglio, C Lovati, I Guidi, D Scalabrini, C Mariani, N Bresolin, E Scarpini: IP-10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease. Eur J Neurol 14, e3-e4 (2007) (Pubitemid 46481147)
88. R Grzanna, P Phan, A Polotsky, L Lindmark, CG Frondoza: Ginger extract inhibits beta-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Altern Complement Med 10, 1009-1013 (2004) (Pubitemid 40185391)
89. Y Sui, L Stehno-Bittel, S L.i., R Loganathan, NK Dhillon, D Pinson, A Nath, D Kolson, O Narayan, S Buch: CXCL10-induced cell death in neurons: role of calcium dysregulation. Eur J Neurosci 23, 957-964 (2006) (Pubitemid 43344690)
90. JM Burns, BC Summers, Y Wang, A Melikian, R Berahovich, Z Miao, ME Penfold, MJ Sunshine, DR Littman, CJ Kuo, K Wei, BE McMaster, K Wright, MC Howard, TJ Schall: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203, 2201-2213 (2006) (Pubitemid 44352240)
91. R Stumm, V Höllt: CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. J Mol Endocrinol 38, 377-382 (2007) (Pubitemid 46723253)
92. A Guyon, JL Nahon: Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity. J Mol Endocrinol 38, 365-376 (2007) (Pubitemid 46723252)
93. A Parachikova, CW Cotman: Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease. Neurobiol Dis 28, 143-153 (2007) (Pubitemid 47615454)
94. C Laske, K Stellos, GW Eschweiler, T Leyhe, M Gawaz: Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease: a contribution to a deficient hematopoietic brain support? J Alzheimers Dis 15, 83-95 (2008)
95. JF Bazan, KB Bacon, G Hardiman, W Wang, K Soo, D Rossi, DR Greaves, A Zlotnik, TJ Schall: A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640-644 (1997)
96. Y Pan, C Lloyd, H Zhou, S Dolich, J Deeds, JA Gonzalo, J Vath, M Gosselin, J Ma, B Dussault, E Woolf, G Alperin, J Culpepper, JC Gutierrez-Ramos, D Gearing: Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387, 611-617 (1997) (Pubitemid 27248766)
97. K Hatori, A Nagai, R Heisel, JK Ryu, SU Kim: Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 69, 418-426 (2002) (Pubitemid 34809490)
98. T Mizuno, J Kawanokuchi, K Numata, A Suzumura: Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 979, 65-70 (2003) (Pubitemid 36798062)
99. AE Cardona, EP Pioro, ME Sasse, V Kostenko, SM Cardona, IM Dijkstra, D Huang, G Kidd, S Dombrowski, R Dutta, JC Lee, DN Cook, S Jung, SA Lira, DR Littman, RM Ransohoff: Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9, 917-924 (2006) (Pubitemid 43980506)
100. TS Kim, HK Lim, JY Lee, DJ Kim, S Park, C Lee, CU Lee: Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 436, 196-200 (2008)